Sarcopenia and functional decline: pathophysiology, prevention and therapy. - Wikidata - awgldk - TriplyDB

Sarcopenia and functional decline: pathophysiology, prevention and therapy.

Sarcopenia and functional decline: pathophysiology, prevention and therapy.

http://www.wikidata.org/entity/Q37610099

about

The Contribution of Advanced Glycation End product (AGE) accumulation to the decline in motor function Resistance Training Is an Effective Tool against Metabolic and Frailty Syndromes.A feasibility study of implementing grip strength measurement into routine hospital practice (GRImP): study protocol.Coexisting Frailty, Cognitive Impairment, and Heart Failure: Implications for Clinical Care Effect of including historical height and radius BMD measurement on sarco-osteoporosis prevalence Evaluation of frailty in older adults with cardiovascular disease: incorporating physical performance measures.The nutritional management of COPD: an overview.Skeletal muscle features in myotonic dystrophy and sarcopenia: do similar nuclear mechanisms lead to skeletal muscle wasting?Muscle Strength and Muscle Mass in Older Patients during Hospitalization: The EMPOWER Study.Role of Dietary Protein and Muscular Fitness on Longevity and Aging.Older Adults' Perceptions of Exercising in a Senior Gym

P2860

Q26767495-A08A6F73-8277-4F0A-9C24-6CE7B8637718 Q30408045-DC4FC468-54B3-46FD-8571-8B15D70464FF Q30831803-724F622B-C822-4753-96A8-488D6EFF29E1 Q36294255-007E12C4-9269-4E52-97BB-BE95CEFA628A Q36636415-82DAD5E5-64AD-469C-9E54-508A1141402E Q36876787-18E5AA3E-3825-45AC-AFFF-231EDD1BC078 Q37761029-5A9EA5F2-E7A5-4F85-9DCD-F8388AB9C8FD Q38048633-76938ED6-6D49-4B57-9D7F-8C38FD8B36CC Q47294226-5B6A6344-9CCE-4C29-8EA2-9E8EEC92BAE8 Q48515784-F820B1AB-1044-4502-AC73-88E91C454CB4 Q58296592-47B2438B-F458-4371-B560-F7CCA786EFE3

P2860

Sarcopenia and functional decline: pathophysiology, prevention and therapy.

http://www.wikidata.org/entity/Q37610099

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Sarcopenia and functional decline: pathophysiology, prevention and therapy.

@en

Sarcopenia and functional decline: pathophysiology, prevention and therapy.

@nl

type

label

Sarcopenia and functional decline: pathophysiology, prevention and therapy.

@en

Sarcopenia and functional decline: pathophysiology, prevention and therapy.

@nl

prefLabel

Sarcopenia and functional decline: pathophysiology, prevention and therapy.

@en

Sarcopenia and functional decline: pathophysiology, prevention and therapy.

@nl

P1433

Q37610099-FA9E0A05-04E0-451C-B0FB-2483415C593B

P1476

Q37610099-6BD4E668-E6AC-494E-9947-BA9F24033640

P2093

Q37610099-93F9B63C-7498-4C59-88E0-8E8BAC98CB54

Q37610099-EA201B99-91D3-40ED-9AAD-7BB674F450AC

P2860

Q37610099-084D71AD-B5F6-4752-8030-A92D483A5B92

Q37610099-156A813E-A59B-4852-944E-DDF9F4B907EF

Q37610099-15FB769A-5770-44E3-926E-D15A69451580

Q37610099-1A9D932E-EF3C-4255-A3B6-CD43E2171336

Q37610099-20465837-0B56-47F7-812D-9EAEBBFACF65

Q37610099-22A8530C-22FB-404E-BCC5-2DF21EAECB80

Q37610099-26957064-39DC-41D7-A386-41582DF608BA

Q37610099-27C8610A-F4E1-40D8-B9AF-DD8E72ADC712

Q37610099-2AB7F6B8-5044-417C-970F-9B106A01CD0D

Q37610099-2CBBF320-011A-485D-AFCF-AD54B7B9ACD2

P304

Q37610099-50488810-02E4-4CF0-960C-1F49968FE799

P31

Q37610099-6211D652-5580-49D4-9630-BBFACE3C1D9A

P356

Q37610099-FF01A300-08D1-472B-8CDF-AE78D90918CE

P433

Q37610099-16A57DDB-522E-4818-94A0-27E66E6831F0

P478

Q37610099-EF3E33F9-8F31-4871-A367-97E607EA33EB

P50

Q37610099-A50E3719-3B34-430E-BC1B-E2EBCC809359

P577

Q37610099-40B52917-A377-4EF5-97BD-F455608DA43B

P5875

Q37610099-4D236F59-7E59-4373-BC69-E3F2D024C0D0

P698

Q37610099-F6446731-0E97-4234-BFD3-783A462082CD

P921

Q37610099-B1E2C4CD-32C1-4820-AE24-EF1E8E075A7F

P356

P1433

Acta Clinica Belgica

P1476

Sarcopenia and functional decline: pathophysiology, prevention and therapy

@en

P2093

Katrien Van Puyvelde

http://www.w3.org/2001/XMLSchema#string

Tony Mets

http://www.w3.org/2001/XMLSchema#string

P2860

The feasibility of Whole Body Vibration in institutionalised elderly persons and its influence on muscle performance, balance and mobility: a randomised controlled trial [ISRCTN62535013]

AMPK and PPARdelta agonists are exercise mimetics

Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue

The six-minute walk test in community dwelling elderly: influence of health status

Frailty in older adults: evidence for a phenotype

Epidemiology of sarcopenia among the elderly in New Mexico

Acute-phase proteins and other systemic responses to inflammation

Review Article: Sarcopenia: Causes, Consequences, and Preventions

Handgrip performance in relation to self-perceived fatigue, physical functioning and circulating IL-6 in elderly persons without inflammation

Recent developments in vitamin D deficiency and muscle weakness among elderly people.

P304

303-316

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1179/ACB.2009.048

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26877332

http://www.w3.org/2001/XMLSchema#string

P698

19810417

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology